Tag Archives: #regulatorywriting

Predictive Analytics in Medical Research: The Role of AI

Medical Writing, Publication Writing, ,

In the rapidly evolving field of medical research, the application of artificial intelligence (AI) has brought transformative changes. Among the various AI-driven technologies, predictive analytics has emerged as a crucial tool. By leveraging historical data, statistical algorithms, and machine learning techniques, predictive analytics can forecast future trends and outcomes with remarkable accuracy. For medical writers, understanding and utilizing predictive analytics can significantly enhance their work’s quality and impact, especially in medical communication.

The Evolution of Predictive Analytics in Medical Research

Predictive analytics in medical research is not a novel concept. Traditionally, researchers have used statistical methods to analyze data and make predictions. However, the advent of AI has revolutionized this process by enabling the analysis of vast datasets with greater speed and precision. AI-powered predictive analytics can identify patterns and correlations that might be missed by human analysis, thus offering deeper insights and more accurate predictions.

Key Components of Predictive Analytics

  1. Data Collection and Preparation: The foundation of predictive analytics lies in collecting high-quality data. This data can come from various sources, including electronic health records (EHRs), clinical trials, and real-world evidence (RWE). Preparing this data involves cleaning, normalizing, and structuring it to ensure it is suitable for analysis.
  2. Model Development: AI algorithms are trained on historical data to develop predictive models. These models can range from simple linear regression to complex neural networks, depending on the nature of the data and the prediction goals.
  3. Validation and Testing: Before deploying predictive models, they must be validated and tested to ensure their accuracy and reliability. This involves comparing the model’s predictions with actual outcomes to assess its performance.
  4. Deployment and Monitoring: Once validated, predictive models are deployed in real-world settings. Continuous monitoring is essential to ensure the model remains accurate over time, and adjustments may be needed based on new data.
  5. Integration with Clinical Workflows:
    1. API development for model deployment
    2. User interfaces for healthcare professionals
    3. Integration with existing health information systems
  6. Continuous Monitoring and Updating:
    1. Performance tracking over time
    2. Model retraining with new data
    3. Drift detection and handling
  7. Ethical and Regulatory Compliance:
    1. Ensuring patient privacy and data security
    2. Addressing bias and fairness in AI models
    3. Compliance with healthcare regulations (e.g., HIPAA, GDPR)
  8. Domain Expertise:
    1. Collaboration with medical professionals
    2. Incorporation of clinical guidelines and medical knowledge
    3. Validation of AI findings against established medical practices

The Role of Predictive Analytics in Medical Communication

Enhancing Clinical Trial Reporting

One of the most significant applications of predictive analytics in medical communication is in the reporting of clinical trials. Medical writers are often tasked with summarizing complex trial data and presenting it clearly and concisely. Predictive analytics can streamline this process by:

  1. Disease prediction and risk assessment: AI algorithms can analyze patient data to predict the likelihood of developing certain diseases or health conditions. This helps in early intervention and preventive care.
  2. Drug discovery and development: AI can accelerate the drug discovery process by analyzing vast amounts of molecular and clinical data to identify potential drug candidates and predict their efficacy and safety.
  3. Personalized treatment plans: By analyzing patient data, genetic information, and treatment outcomes, AI can help develop personalized treatment plans tailored to individual patients.
  4. Medical imaging analysis: AI algorithms can analyze medical images like X-rays, MRIs, and CT scans to detect anomalies and assist in diagnosis, often catching details that human observers might miss.
  5. Clinical trial optimization: AI can help in patient selection for clinical trials, predict trial outcomes, and optimize trial designs, potentially reducing costs and time to market for new treatments.
  6. Electronic Health Record (EHR) analysis: AI can extract insights from large EHR datasets to identify patterns, predict patient outcomes, and suggest interventions.
  7. Epidemic prediction and management: AI models can analyze various data sources to predict disease outbreaks and help in resource allocation during epidemics.
  8. Biomarker discovery: AI can analyze complex biological data to identify new biomarkers for diseases, aiding in early detection and treatment monitoring.
  9. Healthcare resource allocation: Predictive models can help healthcare systems optimize resource allocation by forecasting patient admissions, length of stay, and required care.
  10. Precision medicine: AI supports the advancement of precision medicine by analyzing genetic, environmental, and lifestyle factors to predict treatment responses.

Personalizing Patient Communication

Effective patient communication is crucial in medical practice, and predictive analytics can play a pivotal role in personalizing this communication. Medical writers can leverage predictive models to:

  1. Tailor Information Delivery: Predictive analytics can segment patients based on their medical history, preferences, and behaviors. This allows medical writers to tailor educational materials and communication strategies to meet the specific needs of different patient groups.
  2. Forecasting Patient Outcomes: By analyzing patient data, predictive models can forecast individual patient outcomes, such as disease progression or response to treatment. This information can be used to create personalized care plans and educational content that addresses the unique concerns of each patient.
  3. Improving Engagement: Predictive analytics can identify the most effective communication channels and formats for different patient demographics. This ensures that information is delivered in a manner that maximizes patient engagement and comprehension.

Advancing Publication Planning

In the realm of medical publication, predictive analytics can enhance the planning and execution of publication strategies. Medical writers can benefit from:

  1. Identifying High-Impact Research Areas: Predictive models can analyze trends in scientific literature and clinical research to identify emerging areas of interest. This helps medical writers focus on topics that are likely to have a significant impact on the field.
  2. Optimizing Submission Strategies: By analyzing historical publication data, predictive analytics can suggest the most appropriate journals and conferences for submitting research. This increases the likelihood of acceptance and maximizes the visibility of the work.
  3. Forecasting Citation Impact: Predictive models can estimate the potential citation impact of a publication based on various factors, such as the journal’s reputation and the relevance of the research topic. This information can guide strategic decisions in publication planning.

Challenges and Considerations

While the benefits of predictive analytics in medical research and communication are substantial, several challenges needs to be addressed:

  1. Data Quality and Integrity: The accuracy of predictive models depends heavily on the quality of the input data. Ensuring data integrity and addressing issues such as missing or biased data are critical.
  2. Ethical and Privacy Concerns: The use of patient data in predictive analytics raises ethical and privacy considerations. It is essential to implement robust data protection measures and adhere to ethical guidelines to maintain patient trust.
  3. Model Transparency and Interpretability: Complex AI models, such as deep learning algorithms, can sometimes function as “black boxes,” making it difficult to understand how they arrive at their predictions. Developing transparent and interpretable models is crucial for gaining the trust of stakeholders.
  4. Continuous Learning and Adaptation: Predictive models must be continuously updated with new data to maintain their accuracy. This requires ongoing investment in data collection, model development, and validation.

The Future of Predictive Analytics in Medical Communication

The integration of predictive analytics into medical research and communication is poised to grow as AI technologies advance. Staying abreast of these developments and acquiring the necessary skills to leverage predictive analytics will be essential for medical writers.

In the future, we can expect predictive analytics to become more sophisticated, offering even greater insights and more precise forecasts. This will enhance the ability of medical writers to communicate complex medical information effectively, ultimately improving patient care and advancing medical knowledge.

Predictive analytics, powered by AI, is transforming the landscape of medical research and communication. For medical writers, harnessing these technologies offers a unique opportunity to enhance the quality and impact of their work. By understanding and applying predictive analytics, medical writers can forecast trends, personalize patient communication, and optimize publication strategies, contributing to the advancement of medical science and patient care. As the field continues to evolve, embracing these tools will be crucial for staying at the forefront of medical communication.

Here is Everything You Should Know About Cystic Fibrosis

Updates, , , , , , ,

The month of May is commemorated as Cystic Fibrosis Awareness Month. It aims at raising awareness about cystic fibrosis (CF). Cystic fibrosis foundation (CFF) sponsors this month.

According to estimates, more than 70,000 people globally are affected by cystic fibrosis, but the prevalence of the condition varies globally. The US alone accounts for around 30,000 people living with cystic fibrosis. Around 1000 new cases of cystic fibrosis are diagnosed every year in the US. More than 75% of these cases are of children of age 2 or below. Asia and Africa are thought to be under-diagnosed for CF. Many nations don’t screen for CF in new-borns unlike the US, and the nation registries suffer from lack of data.

What is Cystic Fibrosis (CF)?

CF is a genetic disease that has an impact on lungs and digestive system of human body. Under the influence of this condition, the body produces thick and sticky mucus that can lead to blockage of lungs and obscure pancreas.

In individuals with CF, metamorphosis in the cystic fibrosis transmembrane conductance regulator (CFTR) gene makes the CFTR protein debilitated. When this protein doesn’t function properly, it is incapable of moving chloride- a salt component- to the surface of cell. Without the chloride to bring water to the surface of cell, the mucus in different organs turns thick and sticky.

The mucus blocks the airways and entrap germs such as bacteria, in the lungs, which lead to infections, soreness, respiratory issues and other complications. The people with CF need to be extra cautious and avoid contact with germs.

The thickening of mucus can also lead to infertility in males by clogging the vas deferens or the tube responsible for carrying sperms from testes to urethra.

Symptoms of CF:

Mentioned below are some prominent symptoms of cystic fibrosis:

  • Skin tasting very salty
  • Continual coughing
  • Running out of breath
  • Breathing roughly/heavily
  • Persistent lung infections inclusive of pneumonia or bronchitis
  • Problem with gaining weight despite of heavy diet
  • Infertility in males
  • Greasy and heavy stools
  • Troubles with bowel movements
  • Nasal polyps or slight fleshy growth in the nose

Due to the obstruction in lungs, infections like bronchitis and pneumonia can occur in the patient, leading to growth of pathogens. Blockage in pancreas contribute to malnutrition and poor growth. The risk of developing osteoporosis and diabetes is also associated with it.

Causes of Cystic Fibrosis:

Since CF is a genetic disease, to be affected by it one is required to inherit the mutated gene from both of their parents. The mutated genes are the carriers of codes that produce protein controlling the flow of salt and water on the surface of organs, inclusive of pancreas and lungs.

People suffering from CF struggle with the balance of salt and this leads to more salt and water on the surface of cells and formation of very thick mucus.

Individuals with a single copy of the mutated gene are known as carriers. They do not fall prey to the condition or symptoms of CF. For someone to be affected by CF, both their parents must be the carriers.

If two people are carriers and have a child together, there are:

  • 25% chances that the kid will have CF
  • 50% chances that the kid will be a carrier, but won’t suffer from CF
  • 25% chances that the kid will neither be the carrier and nor suffer from CF

Treatment for CF:

At present, CF is not curable. Certain treatments work on controlling the symptoms and improving quality of life for CF patients. Depending on the kind and intensity of symptoms, the treatments are personalized.

Clearing airway

It is very important for CF patients to reduce the level of mucus in their lungs in order to breathe easily and avoid any lung infections.

Airway Clearance Techniques (ACT) helps individuals with CF to soften their mucus and get rid of it from their lungs. Inhalable medications are effective in reaching the airways and are usually used. The medication can be given through aerosol or through inhalers. These medications help in thinning mucus, killing bacteria and setting off mucus to enhance airway clearance.

Antibiotics act as an essential part of routine care. These can be consumed orally, through injecting and inhalation. Some other medications like azithromycin and ibuprofen are said to protect and enhance lung function and now made a part of standard therapy for CF patients.

CF patients can lower the risk of developing lung infections by taking the below mentioned steps:

  • Washing hands often
  • Avoid smoking
  • Avoid futile contact with people suffering from cold or other contagious diseases
  • Getting a flu injection every year

Other styles of treatment:

Other than the airway clearance technique, there are other types of treatment too.

Implanted devices:

These allow long-term contact with the bloodstream for constant supervision of drugs. These are capable of making the management of CF more powerful and less invasive.

CFTR Modulators:

CFTR (CF Transmembrane Conductance Regulator) modulators are the recent medications developed to focus on the defective CF-causing gene. They help in easing the flow of salt and fluids on the expanse of lungs and weed out the heavy mucus that CF patients generally form in their lungs.

At present, two CFTR modulator brands are certified by FDA (Food and Drug Administration), namely Orkambi and Kalydeco. They’re recommended for children suffering from 10 distinct mutations of the CF-causing gene. Kalydeco might be recommended for kids of age 2 years or more, whereas Orkambi is for kids aged 6.

Remedial measures based on Nutrition:

CF affects the digestive system adversely and the patient suffers from poor nutrient absorption. It is recommended that CF patients should consult their doctor regarding their diet. A nutritionist would assist them in having a control of digestive symptoms.

To balance the digestion of nutrients, a variety of additional supplements like pancreatic enzyme supplements, vitamins or salt might be required along with a specific kind of diet.

CF is responsible flawed growth. To ensure proper development and growth in affected children, a diet rich in calorie and fat, is very essential. It also helps adults in maintaining optimum health. Good nutrition is very crucial for CF patients so that they can be safeguarded against high risk of lung infection.

Cystic fibrosis cannot be cured as of now but with proper care, treatment and diet, the symptoms of it can be controlled. The average life expectancy of CF patients is early 40s. The life expectancy may vary based on the intensity of the symptoms, age of diagnosis and the kind of mutation in gene.

The life expectancy of CF patients has increased significantly in last few years, being around 47 years. There are many patients living well in their 50s or 60s.

Turacoz healthcare solutions, a medical communications firm, believes that appropriate treatment and caution is the key to control currently incurable diseases like cystic fibrosis. Turacoz provides cost-effective medical writing services like regulatory writing, publication writing, advisory board meetings, etc. To know more about Turacoz and to avail the services, drop a mail at [email protected]

Moving to Virtual Clinical Trials

Clinical Trials, , , , ,

 

In the clinical trials industry, 80% of trials do not meet enrolment timelines, leading to a loss of $8 million per day. Delayed enrolment not only impacts trial timelines, but more trials are being cancelled because of it, preventing investigators from determining the safety and efficacy of what could be promising new therapies for patients who need them the most.  This loss can be dealt through incorporation of virtual clinical trials. Unlike traditional site based clinical trials, virtual clinical trials do not require multiple study sites. Though some research space will be required for management of a virtual clinical trial, it can generally be organized from a single facility. Also, patients need not be in proximity to sites, and the data collection requirements fit more easily into their everyday routines, improving compliance and patient engagement. Greenlight insights reported that virtual industry will reach $7.2 billion by the end of 2017, and is expected to touch $74.8 billion by 2021.

Virtual clinical trial is a new method of collecting safety and efficacy data from trial participants, from scratch of the study through execution to follow-up. The participant does not have to travel to the trial site and can make use of simple mobile applications to report general information and adverse events. Body temperature and other vital signs are send directly to the electronic data capture records via wearable sensors.

What are the benefits of virtual clinical trials?

The advantages of virtual clinical trials compared to the traditional trials are mentioned below.


Figure 1: Benefits of virtual clinical trials
  1. Maximizes patient availability and enrolment: The patient recruitment phase is longest in clinical trials and almost 80% of the study fails to reach the initial target.
  2. Overcome of mobility issues: As the patient is not required to travel to the trial site or doctor’s office, it is convenient for elderly participants residing in remote area.
  3. Keep subjects engaged with the study: Almost 40% of the phase III clinical trials subjects drop out from the study due to many factors such as inconvenience in travelling, complexity of trial design and data collection procedure. However, virtual clinical trials does not require patient to travel to clinical study sites. Also, the data collection procedure is automated which increases the patient engagement and reduces the dropout rates.
  4. Better data collection: Data collection is made easy by electronic data capture records hence; the timelines can be achieved at a faster rate.
  5. Benefits to research team: With notifications, scheduling and reporting functions, researchers are freed from performing tedious administrative duties.
  6. Reduce risk in drug development process: Real-time data analysis and data cleaning can be carried out simultaneously. Based on the real time clinical trial data, decisions to terminate drugs development can be made faster.
  7. Cost effectiveness: The reduced number of sites involved in the study leads to reduction of the cost. While trial staff will likely still be based at a single site or a reduced number of sites in multi-site trials, the operating costs will be significantly lower.

Key challenges of virtual clinical trials

  1. Sometimes
    technology may fail:     When everything
    relies on technology, challenge arises if it won’t operate optimally.
  2. Data accuracy
    problems:     As the patients will not face the
    doctor directly, doubts exist whether ideal standard treatment care is provided
    for the patient.
  3. Conservative in
    approach:     Corporate conservatism is another
    major challenge as it is difficult for the sponsors to move on from traditional
    method and trust the data generated from virtual clinical trials.
  4. Challenges in
    device selection:      There are concerns that the device model, the position at which the
    trial participants wear it and other factors could introduce variability into
    the trial results.

Pioneers in virtual clinical trials

REMOTE (Research on Electronic Monitoring of Overactive Bladder Treatment Experience) trial by Pfizer in 2011 was the first virtual clinical trial. Though, the trial faced many challenges, it was the first trial to use web and smartphone based patient recruitment. Also, the patients were not required to visit the study site.

Turacoz Healthcare Solutions aims to provide information regarding the latest trend in clinical trial industry. Turacoz is a medical communications company, which offers services to healthcare professionals in clinical research, regulatory writing, publication writing, medico-marketing writing, and support for conducting medical advisory board meetings.

To know more about us and our services, write to us at [email protected]

New Drugs For HIV: Making An Impact On HIV Treatment

Drugs and Disease, , , , , , , ,

The global statistics for HIV/AIDS 2017 have revealed that around 37 million people across the globe were affected by HIV, out of which 1.8 million were children. 1.8 million new cases of HIV were registered in 2017, making it about 5,000 new cases per day.

Around 75% of the total people affected by HIV were aware of their condition, whereas the rest 25% were yet to be examined. HIV screening is very important and crucial for its prevention and treatment. 21.7 million HIV positive people, globally, were having the access to antiretroviral therapy (ART).

Though the deaths due to AIDS have been reduced by 51 %, globally, there is still a lot to be done for this condition. Till date, we have no cure for HIV. There are various advancements in the drugs for HIV treatment, but there hasn’t anything been invented yet that can cure HIV forever. In such a case, every new drug invented and approved is a ray of hope for many HIV patients worldwide.

New drugs approval for HIV:

Recently, the US Food and Drug Administration gave its approval to two new drugs developed for treating HIV-1, the most common form of the virus.

Over the decades, this disease has been researched upon and understood by various scientists and efforts have been made to find treatment for the same. This approval signifies the potential and improvement in the treatment of the ailment and states that the options for treating the condition have now increased.

Known drug manufacturer, Merck, announced that FDA have approved the two new antiretroviral drugs- Delstrigo & Pifeltro.

These oral medications are targeted toward those adult HIV patients who have not been exposed to antiretroviral treatments before. These medications aren’t meant for the patients who have been previously receiving the antiretroviral treatments.

The approval for these drugs was granted posted the successful phase 3 clinical trial of these 2 drugs. The trial involved 700 participants for each drug. Both the medicines had same side effect of reducing the cholesterol levels.

People with HIV are now living longer life and with the recent statistics it can be inferred that very soon HIV positive people will live longer than 50 years. In such situation they are most likely to be exposed to issues like high cholesterol. So, in such conditions, the side effects of these drugs can prove beneficial as they lower down the cholesterol.

No single drug is effective for HIV patients. So, people who are looking forward to these drugs must consult their doctor beforehand to figure out the most suited treatment for them.

Choosing a certain drug or treatment regimen depends highly on various factors such as other medical issues faced by the patient, possible side effects and drug interactions. As more and more drug being available for the treatment, customized treatments can be generated keeping in mind patient’s condition.

The complexity of HIV/AIDS is still highly misunderstood by people in general and a lot is yet to be done in treatment of HIV.

Turacoz Healthcare Solutions hopes that more and even better drugs will be manufactured in near future which will make a positive impact on the treatment of HIV/AIDS and hopes that the new drugs manufactured will help in treating HIV and benefit HIV positive people.

Being a medical communication company, Turacoz wishes for HIV positive people to live a long and healthy life. Turacoz offers medical writing services like clinical trial support, pharmacovigilance support, regulatory writing, etc. and is updated on the recent advancements in the treatment of various diseases.

To know more, write us at [email protected]

Transparency in Scholarly Publishing

Publication Writing, , , , , , ,

A research publication is considered as the highest-level medium of dissemination of research findings. Scholarly publications play an important role in disseminating findings, thoughts, and analysis to the scientific, academic, and lay communities. Transparency is an ethic that strengthens the credibility and integrity of research work as well as bonding among the scholarly communities. Due to frequent questioning on research credibility, pressure for open access by governments, and high incidences of research frauds, it has become important to form and follow the principles of transparency.

Principles of Transparency

The Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME) together have structured the principles of transparency, discuss all aspects of publication ethics and formulate the best practices to overcome any issue in this regard. The various principles of transparency and best practice in scholarly publishing are described as under:

These principle also help in differentiating the legitimate journals and publishers from the non-legitimate ones.

As per transparency, the scholars should give an access to the research data and methods employed for deriving the conclusion. The data production methods should be shared in a much wider platform. If scholar’s research is based on another researcher’s data, he or she should always cite their data clearly. The rules of data confidentiality, wherever applicable should be followed ethically.

Both the perspectives of transparency, viz. transparency in policy context and transparency in research process should be followed to make the scholarly publishing stronger and more reliable.

Publication plan carrying complete information about all types of publications or articles to be formed from the research or clinical studies also contributes towards ethical practice. A proper and firm publication planning can help researchers follow appropriate publishing practices, in time publication of research and hence, increased transparency.

Turacoz Healthcare Solutions (THS) provides end-to-end medical publication writing support including scholarly or academic publication, research publication, manuscripts, slide deck as well as regulatory writing support for clinical trials which includes Prescribing Information (PI), Investigator Brochures (IBs), Protocols, Clinical Study Reports (CSRs), Clinical Evaluation Reposts (CERs) and Common Technical Documents (CTDs). Our documents are guideline compliant and are as per the current pharma and the healthcare standards. We aim to extend our services to different domains of the industry around the globe.